2021-10-27 来源 : VIP说
参考文献
1. Park H J , Kim G H , Kim K W , et al. Comparison ofRECIST 1.1 and iRECIST in Patients Treated with Immune Checkpoint Inhibitors: ASystematic Review and Meta-Analysis[J]. Cancers, 2021, 13(1):120.
2. Mulkey F , Theoret M R , Keegan P , et al.Comparison of iRECIST versus RECIST V.1.1 in patients treated with an anti-PD-1or PD-L1 antibody: pooled FDA analysis[J]. Journal for ImmunoTherapy of Cancer,2020, 8(1):e000146.
3. Patricia, Guyot, AE, et al. Enhanced secondaryanalysis of survival data: reconstructing the data from published Kaplan-Meiersurvival curves[J]. Bmc Medical Research Methodology, 2012, 12, 9.
版权声明:本网站所有注明来源“医微客”的文字、图片和音视频资料,版权均属于医微客所有,非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源:”医微客”。本网所有转载文章系出于传递更多信息之目的,且明确注明来源和作者,转载仅作观点分享,版权归原作者所有。不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。 本站拥有对此声明的最终解释权。
发表评论
注册或登后即可发表评论
登录注册
全部评论(0)